See more : Zug Estates Holding AG (0QPW.L) Income Statement Analysis – Financial Results
Complete financial analysis of Public Joint-Stock Company Pharmacy Chain 36.6 (APTK.ME) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Public Joint-Stock Company Pharmacy Chain 36.6, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Shanghai Pudong Development Bank Co., Ltd. (600000.SS) Income Statement Analysis – Financial Results
- Cult Food Science Corp. (CULTF) Income Statement Analysis – Financial Results
- Chase Packaging Corporation (WHLT) Income Statement Analysis – Financial Results
- Alphaform AG (AFRMF) Income Statement Analysis – Financial Results
- Mah Sing Group Berhad (8583.KL) Income Statement Analysis – Financial Results
Public Joint-Stock Company Pharmacy Chain 36.6 (APTK.ME)
About Public Joint-Stock Company Pharmacy Chain 36.6
Public Joint-Stock Company Pharmacy Chain 36.6 operates pharmacies in Russia. Its pharmacies offer health and beauty products. The company serves customers under the 36.6, Romir, and Gorzdrav brands. Public Joint-Stock Company Pharmacy Chain 36.6 was founded in 1991 and is based in Moscow, Russia.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 59.05B | 44.10B | 39.27B | 46.05B | 44.66B | 48.25B | 45.95B | 31.89B | 19.07B | 11.91B | 20.92B | 21.59B | 20.38B | 21.06B | 30.72B | 20.77B | 14.37B | 8.64B | 6.05B |
| Cost of Revenue | 38.86B | 28.95B | 25.70B | 32.94B | 38.82B | 37.42B | 36.22B | 23.10B | 13.57B | 8.92B | 13.36B | 11.92B | 11.97B | 12.76B | 20.16B | 14.58B | 9.39B | 5.30B | 3.72B |
| Gross Profit | 20.19B | 15.16B | 13.57B | 13.11B | 5.84B | 10.83B | 9.72B | 8.79B | 5.50B | 2.99B | 7.56B | 9.67B | 8.41B | 8.30B | 10.56B | 6.19B | 4.98B | 3.33B | 2.33B |
| Gross Profit Ratio | 34.20% | 34.36% | 34.56% | 28.47% | 13.08% | 22.45% | 21.16% | 27.55% | 28.85% | 25.09% | 36.15% | 44.80% | 41.25% | 39.42% | 34.38% | 29.79% | 34.68% | 38.60% | 38.49% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00M | 0.00 | 22.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.10B | 894.00M | 226.00M | 472.00M | 499.00M | 312.00M | 123.00M | 153.00M | 126.00M | 91.00M | 69.00M | 7.89B | 7.15B | 7.36B | 10.30B | 7.48B | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 368.00M | 213.00M | 645.00M | 1.04B | 1.16B | 780.00M | 924.00M | 371.00M | 479.00M | 340.00M | 1.42B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.47B | 1.11B | 871.00M | 1.52B | 9.94B | 14.61B | 14.88B | 9.11B | 605.00M | 431.00M | 1.49B | 7.89B | 7.15B | 7.36B | 10.30B | 7.48B | 4.64B | 2.91B | 2.01B |
| Other Expenses | 18.72B | 296.00M | 11.65B | 12.27B | 338.00M | -9.00M | -12.00M | -62.00M | 5.26B | -22.00M | 64.00M | 5.00M | 15.20M | 483.40M | -30.11M | -87.22M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 20.19B | 13.89B | 12.53B | 13.78B | 9.94B | 14.62B | 14.89B | 9.17B | 5.87B | 5.46B | 6.93B | 7.89B | 7.15B | 7.36B | 10.28B | 7.54B | 4.64B | 2.91B | 2.01B |
| Cost & Expenses | 59.05B | 42.84B | 38.22B | 46.72B | 48.76B | 52.04B | 51.11B | 32.27B | 19.43B | 14.38B | 20.29B | 19.81B | 19.12B | 20.12B | 30.43B | 22.11B | -14.03B | -8.21B | -5.73B |
| Interest Income | -545.00M | 412.00M | 83.00M | 80.00M | 5.00M | 67.00M | 166.00M | 3.00M | 0.00 | 4.00M | 62.00M | 50.00M | 0.00 | 0.00 | -7.87M | 27.98M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 4.24B | 3.24B | 4.63B | 5.32B | 6.40B | 3.53B | 2.51B | 2.03B | 1.32B | 1.48B | 1.48B | 1.44B | 1.26B | 1.17B | 1.08B | 943.23M | 458.04M | 427.93M | 229.51M |
| Depreciation & Amortization | 5.79B | 5.81B | 5.02B | 4.88B | 5.48B | 1.50B | 1.04B | 424.00M | 163.00M | 229.00M | 404.00M | 457.00M | 477.00M | 481.00M | 633.77M | 500.44M | 351.41M | 219.94M | 201.86M |
| EBITDA | 10.44B | 7.60B | 9.73B | 1.22B | -10.02B | -7.42B | -5.40B | 41.00M | 901.00M | -7.63B | 2.98B | 1.99B | 1.74B | 1.81B | 474.82M | -848.71M | 2.21B | 1.03B | 544.39M |
| EBITDA Ratio | 17.68% | 15.88% | 15.62% | 9.44% | 3.11% | -4.75% | -8.97% | 0.13% | 4.70% | -63.76% | 4.63% | 12.63% | 8.53% | 6.75% | 1.55% | -4.09% | 15.39% | 11.96% | 9.00% |
| Operating Income | 4.80B | 1.20B | 793.00M | -802.00M | -4.09B | -3.79B | -5.17B | -383.00M | 837.00M | -7.81B | 2.34B | 1.78B | 1.26B | 880.10M | -403.55M | -1.39B | 340.48M | 426.23M | 322.51M |
| Operating Income Ratio | 8.12% | 2.71% | 2.02% | -1.74% | -9.16% | -7.86% | -11.24% | -1.20% | 4.39% | -65.54% | 11.17% | 8.25% | 6.19% | 4.18% | -1.31% | -6.70% | 2.37% | 4.94% | 5.33% |
| Total Other Income/Expenses | -4.38B | -2.70B | -1.69B | -6.10B | -19.31B | -9.35B | -4.23B | -1.43B | -1.42B | -2.44B | -2.60B | -1.80B | -1.30B | -725.20M | -994.39M | -1.10B | 1.06B | -41.65M | -209.49M |
| Income Before Tax | 411.00M | -1.44B | -643.00M | -8.75B | -22.76B | -13.14B | -9.40B | -1.33B | -579.00M | -9.88B | 1.09B | -23.00M | -39.10M | 154.90M | -1.77B | -2.49B | 1.40B | 384.58M | 113.03M |
| Income Before Tax Ratio | 0.70% | -3.27% | -1.64% | -18.99% | -50.95% | -27.23% | -20.46% | -4.17% | -3.04% | -82.98% | 5.22% | -0.11% | -0.19% | 0.74% | -5.76% | -12.00% | 9.76% | 4.45% | 1.87% |
| Income Tax Expense | 188.00M | -492.00M | 349.00M | 110.00M | 220.00M | -43.00M | -54.00M | -170.00M | -384.00M | 170.00M | 223.00M | 265.00M | 393.40M | 129.30M | 381.18M | 229.56M | 266.19M | 127.61M | 83.27M |
| Net Income | 223.00M | -950.00M | -992.00M | -8.86B | -22.98B | -13.10B | -9.35B | -178.00M | -115.00M | -10.40B | -971.00M | -1.03B | -929.60M | -359.40M | -1.67B | -2.98B | 937.43M | 234.73M | 31.77M |
| Net Income Ratio | 0.38% | -2.15% | -2.53% | -19.23% | -51.44% | -27.14% | -20.34% | -0.56% | -0.60% | -87.31% | -4.64% | -4.79% | -4.56% | -1.71% | -5.42% | -14.35% | 6.52% | 2.72% | 0.53% |
| EPS | 0.03 | -0.12 | -0.15 | -1.78 | -9.67 | -4.97 | -8.15 | -0.17 | -0.11 | -82.53 | -7.71 | -8.21 | -7.76 | -0.07 | -0.34 | -0.61 | 103.59 | 25.94 | 3.51 |
| EPS Diluted | 0.03 | -0.12 | -0.15 | -1.78 | -9.67 | -4.97 | -8.15 | -0.17 | -0.11 | -82.53 | -7.71 | -8.21 | -7.76 | -0.07 | -0.34 | -0.61 | 103.59 | 25.94 | 3.51 |
| Weighted Avg Shares Out | 7.63B | 7.63B | 6.81B | 4.98B | 2.38B | 2.64B | 1.15B | 1.06B | 1.09B | 126.02M | 126.02M | 126.02M | 119.75M | 4.88B | 4.88B | 4.88B | 9.05M | 9.05M | 9.05M |
| Weighted Avg Shares Out (Dil) | 7.63B | 7.63B | 6.81B | 4.98B | 2.38B | 2.64B | 1.15B | 1.06B | 1.09B | 126.02M | 126.02M | 126.02M | 119.75M | 4.88B | 4.88B | 4.88B | 9.05M | 9.05M | 9.05M |
No news found for: APTK.ME
Source: https://incomestatements.info
Category: Stock Reports